Search Results

309 search results found

Past Deadline: Sep 29, 2019

P&G Signal Accelerator Innovation Brief Call for Startup Submissions

meeting

Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Tulip

December 5, 2016 | Startup Exchange Video | Duration: 31:41

Natan Linder, Founder, Tulip
Sports, Nutrition & Wellness - Panel Discussion

June 22, 2017 | Startup Exchange Video | Duration: 43:41
Panel Discussion

How can technology improve the lifestyle choices we make and how productive we are at work over time?

As wearables move from measuring physical data to measuring brain health, how can we “listen” to our bodies to minimize stress, and avoid lost productivity?

What nutritional technologies will enable individuals and companies to make the right dietary decisions for healthier and happier lives?

What role do companies play in furthering these changes?

Panelists:

Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health

Matthew Decker, Global Technical Leader - Comfort and Biophysics Group, W.L. Gore & Associates

David T. Thibodeau, Managing Director, Wellvest Capital

Josh Sarmir, Co-Founder & CEO, SplitSage

Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP
Array Insights (formerly Secure AI Labs/SAIL)

Cambridge, MA

Technology

Secure AI Labs is an AI Platform company providing a High-Assurance Federated Learning solution for healthcare. Its products are used by Pharmaceutical and Medical Device companies, Academic Medical Centers, and Research Consortiums to enable Machine Learning and analytics across data sources... More
Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
Sports, Nutrition & Wellness - Industry View - Matthew Decker

June 22, 2017 | Startup Exchange Video | Duration: 15:26

Matthew Decker

Global Technical Leader - Comfort and Biophysics Group,W.L. Gore & Associates
Interpretable AI

March 18, 2019 | Startup Exchange Video | Duration: 18:56

Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Past Deadline: Apr 1, 2019

Startups for Showcase at Takeda in Shonan, Japan on May 23, 9am-5pm

speaker

Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Aria Pharmaceuticals

January 9, 2019 | Startup Exchange Video | Duration: 15:5

Andrew A. Radin & Andrew M. Radin
Synthetic Biology Workshop 2017 - Panel Discussion

September 12, 2017 | Startup Exchange Video | Duration: 47:6

Synthetic Biology Workshop 2017 - Panel Discussion

Search Results

Filter Results